COR - Cencora Inc Stock Analysis
Cencora Inc (COR) is a publicly traded company listed on the Large. It operates in the Medical Distribution industry, part of the broader Healthcare sector. The company has a market capitalization of 54.80B, generates annual revenue of 328.68B, and reports net income of 2.55B. As of the latest data, the stock is trading at 281.67 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company is highly leveraged, which may pose risks during economic downturns or periods of rising interest rates. The dividend yield (0.84%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Buy (4.05), indicating current market sentiment. Institutional ownership is reported at 97.78%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -4.53%, trading within a 52-week range of 244.82 - 377.54.
COR - Cencora Inc
281.67
Analyst Consensus
Buy 4.05
COR – Analyst Rating Summary
- Strong Buy: 5
- Buy: 11
- Hold: 4
- Sell: 0
- Strong Sell: 0
- Total Analysts: 20
| Index: | S&P 500 | P/E: | 21.61 | EPS (ttm): | 13.03 | Insider Own: | 0.49% | Shs Outstand: | 194.56M | Perf Week: | 2.41% |
| Market Cap: | 54.80B | Forward P/E: | 14.22 | EPS next Y: | 19.81 | Insider Trans: | -2.09% | Shs Float: | 193.62M | Perf Month: | 10.17% |
| Income(ttm): | 2.55B | PEG: | 1.27 | EPS next Q: | 4.35 | Inst Own: | 97.78% | Short Float: | 2.85% | Perf Quarter: | -19.51% |
| Revenue(ttm): | 328.68B | P/S: | 0.17 | EPS this Y: | 11.10% | Inst Trans: | 0.58% | Short Ratio: | 3.12 | Perf Half Y: | -17.35% |
| Book/sh: | 17.46 | P/B: | 16.13 | EPS next Y: | 11.42% | ROA: | 3.33% | Short Interest: | 5.53M | Perf Year: | -4.53% |
| Cash/sh: | 11.49 | P/C: | 24.51 | EPS next 5Y: | 11.17% | ROE: | 115.58% | 52W Range: | 244.82 - 377.54 | Perf YTD: | -16.60% |
| Dividend Est.: | 2.37 (0.84%) | P/FCF: | 35.17 | EPS past 3/5Y: | -0.34% - | ROIC: | 16.36% | 52W High: | 377.54 -25.39% | Beta: | 0.57 |
| Dividend TTM: | 2.35 (0.83%) | Quick Ratio: | 0.59 | Sales past 3/5Y: | 10.43% 11.09% | Gross Margin: | 3.46% | 52W Low: | 244.82 15.05% | Perf 5Y: | 135.04% |
| Dividend Ex-Date: | May 15, 2026 | Current Ratio: | 0.95 | EPS Y/Y TTM: | 51.04% | Oper. Margin: | 1.27% | RSI (14): | 55.08 | Volatility: | 1.92% 2.20% |
| Employees: | 51000 | Debt/Eq: | 3.65 | Sales Y/Y TTM: | 5.95% | Profit Margin: | 0.78% | Recom: | 1.61 | Target Price: | 350.58 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 3.59 | EPS Q/Q: | 128.30% | Payout: | 27.63% | Rel Volume: | 0.60 | Prev Close: | 281.48 |
| Sales Surprise: | -3.37% | EPS Surprise: | -1.42% | Sales Q/Q: | 3.85% | Earnings: | May 06 BMO | Avg Volume: | 1.77M | Price: | 281.67 |
| SMA20: | 4.28% | SMA50: | -2.66% | SMA200: | -13.36% | Undervalued: 24.46% | Volume: | 1,061,930 | Change: | 0.07% | |
Graham Classic formula value: 360.84
(P/E=8 * 1g) Min value: 224.3
(current P/E * 2g) Max value: 514.23
Average value: 366.46
About Cencora Inc
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.